Arterne Care Limited 12561578 false 2024-02-01 2025-01-31 2025-01-31 The principal activity of the company is that of the provision of care services. Digita Accounts Production Advanced 6.30.9574.0 true 12561578 2024-02-01 2025-01-31 12561578 2025-01-31 12561578 core:CurrentFinancialInstruments 2025-01-31 12561578 core:CurrentFinancialInstruments core:WithinOneYear 2025-01-31 12561578 core:Non-currentFinancialInstruments 2025-01-31 12561578 core:Non-currentFinancialInstruments core:AfterOneYear 2025-01-31 12561578 core:Goodwill 2025-01-31 12561578 core:BetweenTwoFiveYears 2025-01-31 12561578 core:MoreThanFiveYears 1 2025-01-31 12561578 core:WithinOneYear 2025-01-31 12561578 core:FurnitureFittings 2025-01-31 12561578 core:LandBuildings core:OwnedOrFreeholdAssets 2025-01-31 12561578 core:MotorVehicles 2025-01-31 12561578 bus:SmallEntities 2024-02-01 2025-01-31 12561578 bus:AuditExemptWithAccountantsReport 2024-02-01 2025-01-31 12561578 bus:FilletedAccounts 2024-02-01 2025-01-31 12561578 bus:SmallCompaniesRegimeForAccounts 2024-02-01 2025-01-31 12561578 bus:RegisteredOffice 2024-02-01 2025-01-31 12561578 bus:Director2 2024-02-01 2025-01-31 12561578 bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 12561578 core:Goodwill 2024-02-01 2025-01-31 12561578 core:Buildings 2024-02-01 2025-01-31 12561578 core:FurnitureFittings 2024-02-01 2025-01-31 12561578 core:FurnitureFittingsToolsEquipment 2024-02-01 2025-01-31 12561578 core:LandBuildings 2024-02-01 2025-01-31 12561578 core:LandBuildings core:OwnedOrFreeholdAssets 2024-02-01 2025-01-31 12561578 core:MotorVehicles 2024-02-01 2025-01-31 12561578 core:Vehicles 2024-02-01 2025-01-31 12561578 core:OtherRelatedParties 2024-02-01 2025-01-31 12561578 countries:EnglandWales 2024-02-01 2025-01-31 12561578 2024-01-31 12561578 core:Goodwill 2024-01-31 12561578 core:FurnitureFittings 2024-01-31 12561578 core:LandBuildings core:OwnedOrFreeholdAssets 2024-01-31 12561578 core:MotorVehicles 2024-01-31 12561578 2023-02-01 2024-01-31 12561578 2024-01-31 12561578 core:CurrentFinancialInstruments 2024-01-31 12561578 core:CurrentFinancialInstruments core:WithinOneYear 2024-01-31 12561578 core:Non-currentFinancialInstruments 2024-01-31 12561578 core:Non-currentFinancialInstruments core:AfterOneYear 2024-01-31 12561578 core:Goodwill 2024-01-31 12561578 core:BetweenTwoFiveYears 2024-01-31 12561578 core:MoreThanFiveYears 1 2024-01-31 12561578 core:WithinOneYear 2024-01-31 12561578 core:FurnitureFittings 2024-01-31 12561578 core:LandBuildings core:OwnedOrFreeholdAssets 2024-01-31 12561578 core:MotorVehicles 2024-01-31 iso4217:GBP xbrli:pure

Registration number: 12561578

Arterne Care Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 January 2025

 

Arterne Care Limited

Contents

Statement of Financial Position

1

Notes to the Unaudited Financial Statements

2 to 9

 

Arterne Care Limited

(Registration number: 12561578)
Statement of Financial Position as at 31 January 2025

Note

2025
£

2024
£

Fixed assets

 

Intangible assets

4

172,815

201,617

Tangible assets

5

503,412

507,455

 

676,227

709,072

Current assets

 

Debtors

6

3,099

47,136

Cash at bank and in hand

 

5,736

8,217

 

8,835

55,353

Creditors: Amounts falling due within one year

7

(223,389)

(286,810)

Net current liabilities

 

(214,554)

(231,457)

Total assets less current liabilities

 

461,673

477,615

Creditors: Amounts falling due after more than one year

7

(460,260)

(480,000)

Provisions for liabilities

(5,014)

(4,544)

Net liabilities

 

(3,601)

(6,929)

Capital and reserves

 

Called up share capital

100

100

Profit and loss account

(3,701)

(7,029)

Shareholders' deficit

 

(3,601)

(6,929)

For the financial year ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Statement of Comprehensive Income.

Approved and authorised by the Board on 30 October 2025 and signed on its behalf by:
 


C Willcocks
Director

 

Arterne Care Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Plym House,
3 Longbridge Road
Marsh Mills
Plymouth
Devon
PL6 8LT

Principal activity

The principal activity of the company is that of the provision of care services.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The financial statements are prepared in sterling which is the functional currency of the entity.

 

Arterne Care Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025 (continued)

2

Accounting policies (continued)

Judgements and key sources of estimation uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

Accounting estimates and assumptions are made concerning the future and, by their nature, will rarely equal the related actual outcome.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

Arterne Care Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025 (continued)

2

Accounting policies (continued)

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Property improvements

5% straight line

Fixtures, fittings and equipment

20% straight line

Motor vehicles

25% straight line

Freehold buildings

2% straight line

Impairment

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Goodwill

10% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash at bank and in hand, demand deposits with banks, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value. In the statement of financial position, bank overdrafts are shown within borrowing or current liabilities

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the statement of comprehensive income over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

 

Arterne Care Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025 (continued)

2

Accounting policies (continued)

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

Financial instruments

Recognition and measurement
A financial asset or a financial liability is recognised only when the company becomes party to the contractual provisions of the instrument.

Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 11 (2024 - 12).

4

Intangible assets

Goodwill
 £

Total
£

Cost or valuation

At 1 February 2024

288,024

288,024

At 31 January 2025

288,024

288,024

Amortisation

At 1 February 2024

86,407

86,407

Amortisation charge

28,802

28,802

At 31 January 2025

115,209

115,209

Carrying amount

At 31 January 2025

172,815

172,815

At 31 January 2024

201,617

201,617

 

Arterne Care Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025 (continued)

5

Tangible assets

Land and buildings
£

Fixtures,fittings and equipment
£

Motor vehicles
 £

Total
£

Cost or valuation

At 1 February 2024

496,204

22,723

5,710

524,637

Additions

-

10,246

-

10,246

At 31 January 2025

496,204

32,969

5,710

534,883

Depreciation

At 1 February 2024

6,924

7,954

2,304

17,182

Charge for the year

6,924

5,937

1,428

14,289

At 31 January 2025

13,848

13,891

3,732

31,471

Carrying amount

At 31 January 2025

482,356

19,078

1,978

503,412

At 31 January 2024

489,280

14,769

3,406

507,455

Included within freehold land and buildings is £150,000 (2024 ; £150,000) is respect of land which is not depreciated.

6

Debtors

2025
£

2024
£

Trade debtors

1,787

39,434

Prepayments

1,312

7,702

3,099

47,136

 

Arterne Care Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025 (continued)

7

Creditors

Creditors: amounts falling due within one year

Note

2025
£

2024
£

 

Loans and borrowings

9

20,439

20,000

Trade creditors

 

139,091

203,967

Taxation and social security

 

18,279

9,891

Accruals and deferred income

 

6,498

4,920

Other creditors

 

39,082

48,032

 

223,389

286,810


 

Creditors include bank loans and overdrafts and net obligations under finance lease and hire purchase contracts which are secured of £20,000 (2024 - £20,000).

The loan is secured by a fixed and floating charge over the company's assets and the directors personal property.

Creditors: amounts falling due after more than one year

Note

2025
£

2024
£

Due after one year

 

Loans and borrowings

9

460,260

480,000

2025
£

2024
£

Due after more than five years

After more than five years by instalments

380,260

400,000

£0.00

£0.00

Creditors include bank loans and overdrafts and net obligations under finance lease and hire purchase contracts which are secured of £460,260 (2024 - £480,000).

The loan is secured by a fixed and floating charge over the company's assets and the directors personal property.

 

Arterne Care Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025 (continued)

8

Reserves

Profit and loss account:

This reserve records retained earnings and accumulated losses.

9

Loans and borrowings

Non-current loans and borrowings

2025
£

2024
£

Bank borrowings

460,260

480,000

Current loans and borrowings

2025
£

2024
£

Bank borrowings

20,000

20,000

Other borrowings

439

-

20,439

20,000

10

Obligations under leases and hire purchase contracts

Operating leases

The total of future minimum lease payments is as follows:

2025
£

2024
£

Not later than one year

915

790

Later than one year and not later than five years

381

2,210

1,296

3,000

The amount of non-cancellable operating lease payments recognised as an expense during the year was £963 (2024 - £22,390).

 

Arterne Care Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025 (continued)

11

Related party transactions

Summary of transactions with other related parties

During the year the company had liabilities with related parties, Arterne 2 Nurse Limited and Arterne: Enriching The Next Generation CIC, companies in which the director Cindy Willcocks has an interest.
During the year the company had transactions to the value of £69,494 (2024: £94,072) with Arterne 2 Nurse Limited. At the year end the company owed Arterne 2 Nurse £115,174 (2024 : £129,866).

During the year the company had transactions to the value of £45,713 (2024 : £65,429) with Arterne: Enriching The Next Generation CIC. At the year end the company owed Arterne: Enriching The Next Generation CIC £18,689 (2024 : £72,806)